Pharmaceutical Industry Reports

  • Whitepaper CPHI Milan Wrap-Up Report: Key Insights from the Heart of Pharma

    Celebrating its 35th edition, CPHI Milan was held 8–10 October, 2024 at the historic Fiera Milano exhibition centre. Bringing together over 60,000 attendees worldwide, 2,400 exhibiting companies, and 150 international expert speakers, CPHI Milan connected the global pharmaceutical supply chain for 3 days o...
  • Whitepaper CPHI Annual Report 2024

    The CPHI Annual Report 2024 once again highlights the challenges and opportunities de jour in global pharma, looking ahead to provide vital early insights on the trends and developments that will shape the industry over the next 5-years. The first section provides a review of the Annual CPHI Survey followe...
  • Whitepaper Sustainability Report 2024: a Guide to Growing a Greener Industry

    The pharmaceutical industry is well aware of the impacts of climate change on human health, and increasingly aware of the impact the industry has in contributing to this. Connecting these dots, leaders in the field see how planet health is intrinsically linked to human health, and therefore, must be addres...
  • Whitepaper CPHI Sustainability Trend Report: Towards a Greener Future

    Sustainable supply chain practices within the pharma industry are an increasing concern, as pharma companies look to address the environmental impact of drug development and manufacturing, reduce reliance on non-recyclable materials and assure end-users of steps taken to minimise their carbon footprint. ...
  • Whitepaper The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes

    Pharmaceutical outsourcing strategies have evolved to match the dynamic needs of drugmakers and biotechs. As more and more pharmaceutical companies outsource some percentage of their operations, the partnerships between contracted organisations and drug sponsors are shifting in response to changing priorit...
  • Whitepaper Pharma Trends 2023

    The pharmaceutical industry has witnessed many positive developments in the last year, including 32 novel drug approvals to date, a bivalent COVID-19 vaccine, and the return of face-to-face events. However, 2022 has also presented the pharma market with new geopolitical challenges. Events such as the war i...
  • Whitepaper Trend Report: The Nexus Between Patient and Big Pharma

    Collaborations between contract development and manufacturing organisations (CDMOs) and contract research organisations (CRO) are on the rise. With complex therapeutics in the pipeline and the need for supply chain resiliency, these collaborations can offer more capabilities and services. With such col...
  • Whitepaper Trend Report - Pharma's Next Big Opportunity: Exploring the Potential of Herbal Medicines in Modern Healthcare

    Steeped in centuries of tradition, natural extract products and herbal treatments still face numerous challenges when entering the commercial market. Inconsistent regulations, quality control oversight, and sustainable sourcing and procurement are among some of the top concerns for the pharmaceutical and n...
  • Whitepaper Digital Pharma Marketing Toolkit

    Audiences are plugged into digital marketing more than ever. In our free eBook, we look at how to create and execute a successful digital marketing campaign. From developing an omnichannel presence to creating personalised content, we've got you covered.
  • Whitepaper The 2023 CPHI Annual Report

    Discover fascinating insights from over 250 global industry leaders that illuminate anticipated industry trends in 2024. And dive into a detailed analysis of major pharma markets on various vital metrics.

    Plus, gain the visionary perspectives of global experts shaping the industry today and fore...
  • Whitepaper Trend Report - The True Cost of API Price Rises

    As a direct result of various environmental and socio-political events in the last 2 years, the pharmaceutical industry is grappling with the rise in API pricing across the globe. This report will mainly consider factors in the recent hike in API prices and how these might be directly and indirectly addres...
  • Whitepaper 2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures 

    Our annual Pharma Trends Outlook report delves into the critical challenges facing the pharmaceutical supply chain in 2024. From protecting against supply shortages, quality management maturity, and cross-industry collaboration for sustainability and patient-centred initiatives, the pharmaceutical industry...
  • Whitepaper CPHI Annual Report 2020

    The CPHI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts, as well as the CPHI Pharma Industry Rankings (an annual executive survey of pharma professional). Now in its eight year and launched at the C...
  • Whitepaper CPHI Pharma Post-Pandemic Legacy Trends Report 2021: Out Now!

    This special CPHI Report is split into two halves featuring an expert roundtable, global survey data analysis, and detailed expert contributions.

    In Part one there is an in-depth write-up of the recent Post-Pandemic Roundtable, as well as analysis of the CPHI executive survey data on ‘opportunitie...
  • Whitepaper US Pharma Market Trends 2021

    In interviews with key industry experts, this report identifies ten major and emerging trends that are sure to be prominent in 2021, as US pharmaceutical manufacturing and outsourcing continue to respond not only to the challenges that the ongoing global crisis has presented, but also to evolving obstacles...